MET and non-small cell lung carcinoma: It has been reported that miR-206 suppresses HGF-induced epithelial–mesenchymal transition (EMT) and angiogenesis in non-small cell lung cancer through targetting c-Met/PI3k/AKT/mTOR pathway [22].